GNVR Genvor Inc

Price Chart

Executive Summary

Genvor Inc. entered into a securities purchase agreement with Evergreen Capital Management LLC to raise up to $800,000 through a convertible promissory note, with an initial $166,667 tranche funded. The company also issued warrants to purchase 600,000 shares at $1.00 per share. Concurrently, Genvor engaged Brio Advisory Group for strategic advisory services related to a potential exchange listing, with compensation tied to funding tranches and a future listing.

Key Financial Metrics

Actionable Insight

Key Facts

• Genvor Inc. entered into a securities purchase agreement with Evergreen Capital Management LLC on April 16, 2026.
• The agreement involves a convertible promissory note with a principal amount of up to $800,000, carrying a 20% original issue discount (OID) of $133,332.
• The aggregate purchase price is $666,668, to be paid in four tranches of $166,667 each.
• The first tranche of $166,667 was funded on April 16, 2026, and the note and warrants were issued on that date.
• The note matures 9 months after the issue date (April 15, 2026) or upon a national exchange listing, whichever comes first.
• The note accrues interest at 10% per annum and is convertible into common stock at $1.00 per share, or at a discount upon default.
• Warrants to purchase up to 600,000 shares of common stock were issued, with an initial exercise price of $1.00 per share.
• The warrants have a 5-year term and are exercisable on a cashless basis.
• Genvor also entered into an advisory agreement with Brio Advisory Group on April 16, 2026, for strategic initiatives, capitalization, and exchange listing preparation.
• Compensation for Brio Advisory Group is $300,000 per tranche of funding, valued at the time of an exchange listing or converted to common stock if no listing occurs within one year.

Financial Impact

The company raised $166,667 initially, with potential for up to $800,000 in total funding. The transaction includes a $133,332 OID, which increases the effective cost of capital. The issuance of warrants for 600,000 shares at $1.00 per share represents potential future dilution. The advisory agreement with Brio Advisory Group could result in up to $1,200,000 in compensation, payable in preferred or common stock.

Risk Factors

• The company's ability to secure the remaining funding tranches is contingent on regulatory filings and market conditions.
• The convertible note and warrants could lead to significant dilution for existing shareholders if converted or exercised.
• The company's financial condition and ability to meet its obligations under the note are subject to its ongoing operations and market factors.

Market Snapshot

Documents Analyzed

This report is based on 8 SEC documents filed with EDGAR.

US Market Status